ATE454631T1 - Phosphorylierte sp1 als marker bei der diagnose nichtalkoholischer steatohepatitis (nash) und ziel beim drogenscreening auf nash - Google Patents

Phosphorylierte sp1 als marker bei der diagnose nichtalkoholischer steatohepatitis (nash) und ziel beim drogenscreening auf nash

Info

Publication number
ATE454631T1
ATE454631T1 AT05077320T AT05077320T ATE454631T1 AT E454631 T1 ATE454631 T1 AT E454631T1 AT 05077320 T AT05077320 T AT 05077320T AT 05077320 T AT05077320 T AT 05077320T AT E454631 T1 ATE454631 T1 AT E454631T1
Authority
AT
Austria
Prior art keywords
nash
phosphorylated
marker
targeting
alcoholic steatohepatitis
Prior art date
Application number
AT05077320T
Other languages
English (en)
Inventor
De La Paz Jose Maria Mato
Original Assignee
One Way Liver Genomics Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by One Way Liver Genomics Sl filed Critical One Way Liver Genomics Sl
Application granted granted Critical
Publication of ATE454631T1 publication Critical patent/ATE454631T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5067—Liver cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT05077320T 2005-03-11 2005-10-11 Phosphorylierte sp1 als marker bei der diagnose nichtalkoholischer steatohepatitis (nash) und ziel beim drogenscreening auf nash ATE454631T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05075602 2005-03-11

Publications (1)

Publication Number Publication Date
ATE454631T1 true ATE454631T1 (de) 2010-01-15

Family

ID=36971474

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05077320T ATE454631T1 (de) 2005-03-11 2005-10-11 Phosphorylierte sp1 als marker bei der diagnose nichtalkoholischer steatohepatitis (nash) und ziel beim drogenscreening auf nash

Country Status (4)

Country Link
US (1) US7632649B2 (de)
AT (1) ATE454631T1 (de)
DE (1) DE602005018739D1 (de)
ES (1) ES2339125T3 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005109006A1 (ja) * 2004-04-23 2005-11-17 Ajinomoto Co., Inc. 非アルコール性脂肪肝炎鑑別方法
EP2157431A1 (de) * 2008-08-11 2010-02-24 One Way Liver Genomics, S.L. Verfahren zur NASH-Diagnose unter Verwendung von Stoffwechselprofilen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6084072A (en) * 1990-04-11 2000-07-04 The Regents Of The University Of Michigan Purified lectin and methods of use
US5854254A (en) * 1994-03-30 1998-12-29 North Shore University Hospital Male contraceptives
US20020137715A1 (en) 2001-01-03 2002-09-26 Alain Mauviel Blocking Sp1 transcription factor broadly inhibits extracellular matrix gene expression in vitro and in vivo: implications for the treatment of tissue fibrosis
US7332299B2 (en) * 2003-02-20 2008-02-19 Glycofi, Inc. Endomannosidases in the modification of glycoproteins in eukaryotes

Also Published As

Publication number Publication date
US20060205023A1 (en) 2006-09-14
ES2339125T3 (es) 2010-05-17
DE602005018739D1 (de) 2010-02-25
US7632649B2 (en) 2009-12-15

Similar Documents

Publication Publication Date Title
WO2006138669A3 (en) Life-like anatomic feature for testing injection of soft tissue fillers
WO2007008080A3 (en) Optical imaging contrast agents
WO2007105027A8 (en) Anticancer drugs conjugated to antibody via an enzyme cleavable linker
WO2010046900A3 (en) Rgd-containing peptidomimetics and uses thereof
ATE492651T1 (de) Moesin, caveolin 1 und yes-assoziiertes protein 1 als prädiktive marker der reaktion auf dasatinib bei brustkrebs
WO2006095086A3 (fr) Traçabilite des anomalies du cycle cellulaire ciblant l'oncologie et la neurodegenerescence.
WO2007018431A3 (en) Triazole-containing releasable linkers and conjugates comprising the same
WO2007149456A3 (en) Methods and compositions for diagnostic and therapeutic targeting of cox-2
WO2008008483A3 (en) Dendrimer based compositions and methods of using the same
SG158919A1 (en) Constructs binding to phosphatidylserine and their use in disease treatment
WO2004074434A3 (en) Methods and compositions for administering therapeutic and diagnostic agents
WO2008021515A3 (en) Methods of determining levels of free amino acids and dipeptides and diagnosing alzheimer's diseases
DE602005025911D1 (de) Kontrastmittel für eine extrazelluläre matrix
ATE502048T1 (de) Fluoreszentes chlorotoxinkonjugat und verfahren zur intraoperativen sichtbarmachung von krebs
ATE511645T1 (de) Testverfahren zum nachweis von antikörpern gegen lysosomenenzyme
DE502004012226D1 (de) Saugstent
GB0718957D0 (en) Optical imaging agents
WO2007000320A3 (de) Verfahren zur diagnose von rheumatischen erkrankungen
ATE335515T1 (de) Morpholinobildgebung und therapie
AR057148A1 (es) Combinaciones farmacologicas para el tratamiento de enfermedades de las vias respiratorias
WO2007005502A3 (en) Methods and compositions for treating diseases targeting cdcp1
WO2008028000A3 (en) Radioimaging moieties coupled to peptidase-binding moieties for imaging tissues and organs that express peptidases
MX2007003518A (es) Agentes formadores de imagenes de inhibidor de metaloproteinasa.
ATE454631T1 (de) Phosphorylierte sp1 als marker bei der diagnose nichtalkoholischer steatohepatitis (nash) und ziel beim drogenscreening auf nash
DE502007005857D1 (de) Isoliertes naturidentisches kollagen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties